Targeting the Persistent HIV-1 Viral Reservoir Using Engineered T cells

使用工程 T 细胞靶向持久性 HIV-1 病毒库

• 批准号: 9109094
• 负责人: James L Riley
• 金额: $ 48万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-01-15 至 2018-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9109094
• 关键词: Affect; Affinity; Antigens; Blood Component Removal; CD4 Positive T Lymphocytes; Cell Count; Cells; Clinical Trials; Data; Engineering; Frequencies; Future; Genes; Goals; Grant; HIV; HIV-1; Highly Active Antiretroviral Therapy; Human; Immune response; In Vitro; Individual; Investigational New Drug Application; Lead; Light; Location; Malignant Neoplasms; Modeling; Mus; Patients; Phase; Phase I Clinical Trials; Proteins; Research Infrastructure; Sampling; T-Cell Activation; T-Cell Immunologic Specificity; T-Lymphocyte; Technology; Testing; Time; Toxic effect; Viral; Viral Genes; abstracting; base; cellular engineering; design; in vitro Model; in vivo; in vivo Model; mouse model; safety testing; vaccine trial

No abstract provided

未提供摘要